This course provides an integrated view of how corporate strategy is delivered through the portfolio of new and lifecycle drug projects. Set in a small group setting, this highly interactive course uses a case study approach to help attendees develop real-world skills in building viable portfolio, strategy, and drug value processes.
COURSE HIGHLIGHTS
•Standard processes for portfolio, strategy, and drug value management.
•How to translate generic processes into pragmatic and viable processes.
•Organizational approaches to drug value creation.
COURSE HIGHLIGHTS
•Standard processes for portfolio, strategy, and drug value management.
•How to translate generic processes into pragmatic and viable processes.
•Organizational approaches to drug value creation.
